英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
063728查看　063728　在百度字典中的解释百度英翻中〔查看〕
063728查看　063728　在Google字典中的解释Google英翻中〔查看〕
063728查看　063728　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Abstracts - American Society of Hematology
    Abstracts submitted for oral and poster presentation at the ASH annual meeting represent important, novel research in the field and are considered the best of the thousands of abstracts submitted
  • Genmab A S Presents Results From Comprehensive Epcoritamab Development . . .
    The following abstracts have been accepted for presentation at ASH: oral presentations include ctDNA-directed intervention with epcoritamab alone or in combination with lenalidomide and rituximab in the early post-CAR-T population at high risk of relapse, epcoritamab plus venetoclax in relapsed or refractory chronic lymphocytic leukemia, a
  • ASH® ANNUAL PROGRAM
    Your gateway to the complete scientific program for the 2026 ASH® Annual Meeting Exposition Seamlessly search, filter, and discover the research most relevant to your focus areas and clinical practice
  • Oral and Poster Sessions - American Society of Hematology
    Oral abstract sessions will be available on the virtual meeting platform live, concurrent with the in-person presentation at the convention center Poster presenters will display a physical copy of their poster in the poster hall on either Saturday, Sunday, or Monday during the ASH annual meeting
  • Dizal to Present Latest Clinical Data at ASH 2026 - PR Newswire
    Two oral presentations will report data from birelentinib, as a monotherapy or in combination with venetoclax, in chronic lymphocytic leukemia and small lymphocytic lymphoma (CLL SLL)
  • Nurix Therapeutics to Present New and Updated Data from . . . - BioSpace
    The presentation abstract was released today by ASH and highlights new and updated data in patients with relapsed refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) with efficacy data reported for those previously treated with covalent BTK inhibitors (cBTKi)
  • ASH® ANNUAL PROGRAM
    2026 ASH® Annual Meeting Exposition December 12-15, 2026 New Orleans, Louisiana American Society of Hematology Meetings Annual Meeting Abstracts Presentations Portal
  • ASH | Annual Meeting
    Search papers by paper title or paper abstract or author co-author name or author institution or topic title or paper number
  • Ascentage Pharma to Present Data from Multiple Trials, Including an . . .
    Ascentage Pharma to Present Data from Multiple Trials, Including an Oral Presentation of APG-5918 at ASH 2026 PRESS RELEASE GlobeNewswire Nov 4, 2026, 06:30 PM
  • Ascentage Pharma to Present Data from Multiple Trials . . . - BioSpace
    The ASH Annual Meeting is one of the largest gatherings of the international hematology community, aggregating the latest scientific research on the pathogenesis and clinical treatment of hematologic diseases The 68th ASH Annual Meeting will take place on December 12-15, 2026, local time, both online and in-person in New Orleans, Louisiana, USA





中文字典-英文字典  2005-2009